Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, IDEAYA Biosciences Inc increased its cash reserves by 129.53%, or 89.04m. Cash Flow from Financing totalled 362.72m or 1,551.07% of revenues. In addition the company used 115.22m for operations while cash used for investing totalled 158.46m.
Cash flow per share | -2.31 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 13.67 |
---|---|
Tangible book value per share | 13.67 |
More ▼
Balance sheet in USDView more
Current ratio | 22.93 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼